Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT06910852
NCT06910852CompletedNot Applicable

Hepatic and Portal Vein Transection by Vascular Stapler in Open Living Donor Hepatectomy

Abdalla Bashir, MD1 site in 1 country17 target enrollmentStarted: June 18, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
17
Locations
1
Primary Endpoint
Post-operative complications (Clavien-Dindo classification)
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

To enhance donor safety in living donor liver transplantation (LDLT), the use of vascular staplers for the division of the right portal and hepatic veins in patients undergoing right lobe liver donation has been introduced. This study examines the application of vascular staplers in LDLT and assesses the subsequent feasibility and safety outcomes for donors.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients undergoing open living donor hepatectomy
  • •Age ≥ 18 years, ≤ 80 years
  • •Written informed consent

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Post-operative complications (Clavien-Dindo classification)

Time Frame: From enrollment to the end of treatment at 6 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Abdalla Bashir, MD
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Abdalla Bashir, MD

MD

Jordan Hospital

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
The Use of Technical Vessel Sealing Devices for Recipient Hepatectomy in Liver TransplantationHepatectomy
NCT03323242University Hospital Heidelberg69
Unknown
Not Applicable
Impact of Splenic Artery Ligation in LDLT for Patients With Portal HypertensionLiving Donor Liver Transplantation
NCT04988100Assiut University30
Completed
Not Applicable
Hepatic and Portal Vein Transection by Vascular Stapler in Living Donor Liver Transplantatioiver transplantB18.19B18.2K74.5E83.0I82.0C22.0Chronic viral hepatitis CBiliary cirrhosis, unspecifiedDisorders of copper metabolismLiver cell carcinomaBudd-Chiari syndrome
DRKS00028573Jordan Hospital Amman17
Completed
Not Applicable
Risk Factors and a nOmogram of Venous thromboEmbolism in Patients After liveR Transplantation(ROVER Study)Liver TransplantationVenous Thromboembolism
NCT05209048Beijing Tsinghua Chang Gung Hospital356
Completed
Not Applicable
Expanding Donor Pool for Live Donor Liver Transplantation: Utilization of Donors With NASH After OptimizationNon Alcoholic Steatohepatitis
NCT04571957Institute of Liver and Biliary Sciences, India410